Cargando…

Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease

IMPORTANCE: Clinical care quality improvement (QI) strategies are critical to prevent and control cardiovascular disease (CVD). However, there is limited evidence regarding which components of the health system–, clinician-, and patient-based QI strategies contribute to their impact on CVD. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Kavita, Bawa, Vidit Singh, Venkateshmurthy, Nikhil Srinivasapura, Gandral, Mareesha, Sharma, Shuchita, Lodhi, Sugandha, Wafford, Q. Eileen, Patel, Shivani A., Tandon, Nikhil, Narayan, K. M. Venkat, Prabhakaran, Dorairaj, Huffman, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204210/
https://www.ncbi.nlm.nih.gov/pubmed/34125220
http://dx.doi.org/10.1001/jamanetworkopen.2021.13375
_version_ 1783708308543111168
author Singh, Kavita
Bawa, Vidit Singh
Venkateshmurthy, Nikhil Srinivasapura
Gandral, Mareesha
Sharma, Shuchita
Lodhi, Sugandha
Wafford, Q. Eileen
Patel, Shivani A.
Tandon, Nikhil
Narayan, K. M. Venkat
Prabhakaran, Dorairaj
Huffman, Mark D.
author_facet Singh, Kavita
Bawa, Vidit Singh
Venkateshmurthy, Nikhil Srinivasapura
Gandral, Mareesha
Sharma, Shuchita
Lodhi, Sugandha
Wafford, Q. Eileen
Patel, Shivani A.
Tandon, Nikhil
Narayan, K. M. Venkat
Prabhakaran, Dorairaj
Huffman, Mark D.
author_sort Singh, Kavita
collection PubMed
description IMPORTANCE: Clinical care quality improvement (QI) strategies are critical to prevent and control cardiovascular disease (CVD). However, there is limited evidence regarding which components of the health system–, clinician-, and patient-based QI strategies contribute to their impact on CVD. OBJECTIVES: To identify, map, and organize evidence on the effectiveness and implementation of cardiovascular QI strategies that seek to improve outcomes in patients with CVD. EVIDENCE REVIEW: Eight electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, the Cochrane Library, ProQuest, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform) were searched for studies published between January 1, 2009, and October 25, 2019. Eligible study designs included randomized trials and preintervention and postintervention evaluations. Descriptive findings of included studies were reported using several frameworks to map the intervention components stratified by target population, setting, outcomes, and overall results. FINDINGS: From 8066 screened titles and abstracts, 456 unique studies with 150 148 unique patients (38.1% women and 61.9% men; mean [SD] age, 64.6 [7.1] years) were identified, including 427 randomized trials, 21 quasi-randomized studies, and 8 preintervention and postintervention studies. Of 336 studies from 45 countries that were classified, 255 (75.9%) were from high-income countries; 68 (20.2%), upper-middle–income countries; 13 (3.9%), lower-middle–income countries; and 0, low-income countries, with diverse clinical settings and target patient populations (post–myocardial infarction, stroke, heart failure). Patient support (311 studies), information communication technology (ICT) for health (78 studies), community support (18 studies), supervision (15 studies), and high-intensity training (14 studies) were the most commonly evaluated QI strategies. Other strategies were group problem-solving (7 studies), printed information (5 studies), strengthening infrastructure (4 studies), and financial incentives (3 studies). Patient support, ICT for health, training, and community support were strategies that had been evaluated the most for clinical end points and showed modest associations with several clinical outcomes. The other strategies did not have outcome-driven evaluations reported. Group problem-solving was associated with improved patient self-care and quality of life. Strengthening infrastructure was associated with improved treatment satisfaction. Printed information and financial incentives showed no meaningful effect. CONCLUSIONS AND RELEVANCE: This systematic review found that substantial variations exist in the types, effectiveness, and implementation of QI strategies for patients with CVD. A comprehensive map of QI strategies created by this study would be useful for researchers to identify where new knowledge is needed to improve cardiovascular outcomes. Outcome-driven evaluations and long-term studies are needed, particularly in low-income settings, to better understand the effects of QI strategies on prevention and control of CVD.
format Online
Article
Text
id pubmed-8204210
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-82042102021-06-17 Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease Singh, Kavita Bawa, Vidit Singh Venkateshmurthy, Nikhil Srinivasapura Gandral, Mareesha Sharma, Shuchita Lodhi, Sugandha Wafford, Q. Eileen Patel, Shivani A. Tandon, Nikhil Narayan, K. M. Venkat Prabhakaran, Dorairaj Huffman, Mark D. JAMA Netw Open Original Investigation IMPORTANCE: Clinical care quality improvement (QI) strategies are critical to prevent and control cardiovascular disease (CVD). However, there is limited evidence regarding which components of the health system–, clinician-, and patient-based QI strategies contribute to their impact on CVD. OBJECTIVES: To identify, map, and organize evidence on the effectiveness and implementation of cardiovascular QI strategies that seek to improve outcomes in patients with CVD. EVIDENCE REVIEW: Eight electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, the Cochrane Library, ProQuest, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform) were searched for studies published between January 1, 2009, and October 25, 2019. Eligible study designs included randomized trials and preintervention and postintervention evaluations. Descriptive findings of included studies were reported using several frameworks to map the intervention components stratified by target population, setting, outcomes, and overall results. FINDINGS: From 8066 screened titles and abstracts, 456 unique studies with 150 148 unique patients (38.1% women and 61.9% men; mean [SD] age, 64.6 [7.1] years) were identified, including 427 randomized trials, 21 quasi-randomized studies, and 8 preintervention and postintervention studies. Of 336 studies from 45 countries that were classified, 255 (75.9%) were from high-income countries; 68 (20.2%), upper-middle–income countries; 13 (3.9%), lower-middle–income countries; and 0, low-income countries, with diverse clinical settings and target patient populations (post–myocardial infarction, stroke, heart failure). Patient support (311 studies), information communication technology (ICT) for health (78 studies), community support (18 studies), supervision (15 studies), and high-intensity training (14 studies) were the most commonly evaluated QI strategies. Other strategies were group problem-solving (7 studies), printed information (5 studies), strengthening infrastructure (4 studies), and financial incentives (3 studies). Patient support, ICT for health, training, and community support were strategies that had been evaluated the most for clinical end points and showed modest associations with several clinical outcomes. The other strategies did not have outcome-driven evaluations reported. Group problem-solving was associated with improved patient self-care and quality of life. Strengthening infrastructure was associated with improved treatment satisfaction. Printed information and financial incentives showed no meaningful effect. CONCLUSIONS AND RELEVANCE: This systematic review found that substantial variations exist in the types, effectiveness, and implementation of QI strategies for patients with CVD. A comprehensive map of QI strategies created by this study would be useful for researchers to identify where new knowledge is needed to improve cardiovascular outcomes. Outcome-driven evaluations and long-term studies are needed, particularly in low-income settings, to better understand the effects of QI strategies on prevention and control of CVD. American Medical Association 2021-06-14 /pmc/articles/PMC8204210/ /pubmed/34125220 http://dx.doi.org/10.1001/jamanetworkopen.2021.13375 Text en Copyright 2021 Singh K et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Singh, Kavita
Bawa, Vidit Singh
Venkateshmurthy, Nikhil Srinivasapura
Gandral, Mareesha
Sharma, Shuchita
Lodhi, Sugandha
Wafford, Q. Eileen
Patel, Shivani A.
Tandon, Nikhil
Narayan, K. M. Venkat
Prabhakaran, Dorairaj
Huffman, Mark D.
Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
title Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
title_full Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
title_fullStr Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
title_full_unstemmed Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
title_short Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
title_sort assessment of studies of quality improvement strategies to enhance outcomes in patients with cardiovascular disease
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204210/
https://www.ncbi.nlm.nih.gov/pubmed/34125220
http://dx.doi.org/10.1001/jamanetworkopen.2021.13375
work_keys_str_mv AT singhkavita assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT bawaviditsingh assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT venkateshmurthynikhilsrinivasapura assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT gandralmareesha assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT sharmashuchita assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT lodhisugandha assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT waffordqeileen assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT patelshivania assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT tandonnikhil assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT narayankmvenkat assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT prabhakarandorairaj assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease
AT huffmanmarkd assessmentofstudiesofqualityimprovementstrategiestoenhanceoutcomesinpatientswithcardiovasculardisease